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The cellular interactions involved in antigen-specific suppressor T  cell path- 
ways are the subject of intense investigation. Although portions of the pathways 
have been elucidated in a  variety of systems, there is no clear-cut information 
from these systems concerning the number of T  cell subsets involved and the 
extent of interactions among  these subsets.  Our  studies of suppressor  T  cell 
subsets have focussed on responses to the synthetic polymers L-glutamic acid  6°- 
L-alanine3°-L-tyrosine  1° (GAT) 1 and L-glutamic acidS°-L-tyrosine  5° (GT). Both of 
these antigens stimulate suppressor T  cells in certain strains of mice (1, 2) and 
extracts of these suppressor T  cells contain factors (TsF) that inhibit GAT- or 
GT-specific antibody responses by normal spleen cells or proliferative responses 
by primed T  cells (3,  5).  The TsF found in these extracts are antigen-binding 
proteins that bear determinants encoded by the I-J subregion of the H-2 gene 
complex (6, 7) and determinants that cross-react with idiotypic determinants on 
antibodies of the same specificity (8). No determinants encoded by IgCH region 
genes have been detected on these factors. GAT-TsF and GT-TsF specifically 
inhibit responses by allogeneic mice (4, 9,  10); this suppression is correlated with 
the induction of a second set of suppressor T  cells (Ts2) (11-13).  Furthermore, 
induction of these Ts2 cells by TsF is antigen dependent (11-13). 
We have previously demonstrated that T  cell hybridomas can be constructed 
which constitutively produce GAT-TsF  or  GT-TsF  that  are functionally and 
serologically identical to factors extracted from or secreted by suppressor T  cells 
(14, 15). In addition, we have shown that monoclonal GT-TsF can induce specific 
unresponsiveness in  vivo or in  vitro and  that this  unresponsiveness correlates 
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with the development of antigen-specific suppressor  T  cells  (Ts2)  (16).  T  cell 
hybridomas have been constructed by fusion of BW5147 with GT-TsFl-induced 
Ts2  cells,  and clones that produce suppressor factor (GT-TsF2) were isolated 
and characterized.  GT-TsF2,  like  GT-TsF1,  is antigen specific in suppressive 
activity and also in its antigen-binding capacity (14).  However, GT-TsF2 differs 
from the  GT-TsF1  used  to  induce  it  in  tbat  GT-TsF1  acts across  ailogeneic 
barriers,  whereas GT-TsF2 does not. This restriction is controlled by genes in 
the H-2 complex and maps to the I-J subregion. Thus, GT-TsF2 closely resembles 
the  carrier-specific,  I-J +,  genetically restricted  factor described  by  Tada  and 
Okumura (17)  and the hapten-specific third-order factors (TsF3) described by 
Okuda et al.  (18).  Hybridomas producing monoclonal GAT-TsF1  and GAT- 
TsF2 were also generated when spleen cells from mice injected with syngeneic 
GAT-pulsed macrophages as neonates were fused with BW5147 as adults (15). 
These factors have properties identical to the GT-TsF1 and GT-TsF2 counter- 
parts described above. 
Studies reported  in  this manuscript demonstrate that these  GT- and GAT- 
specific TsF1  and TsF2 are also structurally distinct suppressor factors. These 
molecules bear antigen-binding sites and determinants encoded by the I-J subre- 
gion; however, these two determinants reside on separate polypeptide chains and 
are  linked by disulfide bonds  in  TsF2,  whereas both  determinants appear  to 
reside on a  single polypeptide chain in  TsF1.  We have prepared  hybridomas 
producing monoclonal TsF2 from mice bearing three different H-2 haplotypes 
(a,  b,  and q)  and have analyzed the ability of isolated antigen-binding chains 
(ABC  +)  and  I-J  +  chains  from  these  three  TsF2  molecules  to  function  when 
recombined with chains derived from other haplotypes. Results reported herein 
demonstrate that mixtures of heterologous chains are not functional, suggesting 
a restriction in the ability of the chains to form biologically active recombinant 
molecules.  Furthermore,  indirect evidence has been  obtained which suggests 
that this restriction is due to the failure of the chains to interact with one another 
rather than the inability of the target cells to recognize both chains. 
Materials and Methods 
Mice.  C57BL/10 (H-2b), B10.BR (H-2k), B10.Q (H-2q), BALB/c (H-2d), B10.S (H-2S), 
(B10 ×  B10.Q)F~ (H-2Wq), and (B10 × CBA)F~ (H-2  wk) mice were bred in the Animal 
Resources Facility at the  Jewish Hospital of St. Louis. Mice were maintained on laboratory 
chow and water  ad  libitum and used when 3-6 mo old. Mice were vaccinated with the 
IHD-T strain of vaccinia virus at 5 wk of age. 
Antigens.  GAT (lot 11 IF) and methylated bovine serum albumin (MBSA) were pur- 
chased from Sigma Chemical Co., St. Louis, MO; GT, lot 10, was purchased  from Miles 
Laboratories  Inc.,  Research  Products  Div., Elkhart,  IN.  GAT, GAT-MBSA, and GT- 
MBSA complexes were prepared to use as antigens in culture as previously described (19). 
Monoclonal  anti-I-J,  WF  9.40.5  Anti-la  (I-J)  Antibodies  and  Immunoadsorbents.  b 
[B 10.A(5R) anti-B 10.A(3R)] and anti-I-J  k, WFS.C 12.8 [B 10.A(3R) anti-B 10.A(5R)] were 
provided by Dr. Carl Waltenbaugh,  Northwestern  University, Evanston, IL (20). Mono- 
clonal antibody that recognizes suppressor factors from H-2  q mice (putative anti-I-Jq; Ky 
35) but not those from H-2  ''b'k ors mice was prepared by Dr. Vera Haupfeid by immunizing 
AKR mice with the T cell hybridoma, 258C4.6, a sister hybridoma isolated from the same 
fusion as 258C4.4 (21). A monoclonal antibody that reacts with suppressor factors from 
several H-2  b T cell hybridomas (putative anti-I-Jh; Ky 81) was prepared from (B 10.BR × 
AKR)F~ mice that had been  immunized  with a  GAT-specific T  cell hybridoma from 1964  SUPPRESSOR  T  CELL  INTERACTIONS 
C57BL/10 mice (21  and Hauptfeld, manuscript in preparation). Spleen cells from im- 
munized mice were fused to the non-Ig-secreting myeloma line Sp2/0 Agl4 and clones 
producing antibodies were selected by immunofluorescence and cytotoxicity against the 
immunizing T  cell hybridomas. Supernatant fluids from these hybridomas (Ky 35, Ky 81, 
WF9.40.5, and WF8.C12.8) were coupled to cyanogen bromide-Sepharose 4B (Sigma 
Chemical Co.) according to the manufacturer's directions. We found that mixing equal 
volumes of swollen beads with supernatant fluids diluted 1:5 in phosphate-buffered saline 
(PBS) reproducibly resulted in >95% of the protein coupling to the beads. Further, these 
beads were capable of absorbing factors bearing the appropriate I-J haplotype. GAT and 
GT were individually coupled to aminohexyl Sepharose 4B (Sigma  Chemical Co.) at 2 
mg/ml as previously described (6). 
Undiluted supernatant fluids from T  cell hybridomas were applied to antigen-coupled 
beads at a ratio of 5 vol of supernatant fluid to 1 vol of Sepharose beads in the presence 
or absence of 5 mM dithiothreitol (DTT). After reacting for 1 h at 4°C, the beads were 
washed with PBS and the effluent was collected; the adsorbed TsF was eluted by reaction 
with 2 M KCI as previously described (6). After dialysis against PBS (pH 7.0) to remove 
the KCI and DTT, TsF was diluted 1:5 with PBS and reacted with anti-I-J-Sepharose 4B 
in a ratio of 5:1 as above. The beads were washed with PBS, the effluent was collected, 
and adsorbed material was eluted with 2 M KCI. Amounts of Tsf added to cultures have 
been corrected for dilution during these procedures as far as possible. 
T Cell Hybridomas.  Production of GAT- and GT-specific TsF1- and TsF2-producing 
bybridomas has  been  described in  detail  (14-16).  Once  the  T  cell hybridomas were 
selected and cloned, they have been maintained as frozen stocks in liquid nitrogen. 
Cell Culture and Assay of T Cell Hybridoma Supernatant Fluids.  Development of primary 
splenic plaque-forming cell (PFC) responses was measured in vitro under modified Misheil- 
Dutton conditions as described previously (15, 19). PFC responses in cultures stimulated 
with 5 #g/ml GAT, GAT-MBSA, GT-MBSA, or 107 sheep erythrocytes (SE) were assayed 
on day 5  using GAT-SE and SE as indicator cells  in a  slide modification of the Jerne 
hemolytic plaque assay. 
Supernatant fluids from hybridoma cultures were diluted and added to assay cultures 
at initiation unless otherwise stated. Unpurified supernatant fluids from suppressor T cell 
hybridomas routinely inhibit specific responses by 75-100% at final dilutions of 1:10,000 
(14-16). Data are presented as GAT-specific IgG PFC/culture or percent control response. 
As a semiquantitative measure of suppressive activity, in some experiments the supernatant 
fluids have been titrated and the data plotted as percent suppression versus the log~0 of 
the inverse of the dilution; those data have been reported as $50 U/mi, the inverse of the 
dilution  that  caused  50%  suppression  derived  by  interpolation.  Active  supernatants 
suppress responses by 75-100% whereas supernatants that suppress responses by <20% 
were considered negative and the titer recorded as less than the inverse of the lowest 
dilution tested, e.g., <10,000. The specificity of these supernatant fluids was verified by 
their addition to cultures stimulated with an irrelevant antigen (SE); none of the factors 
inhibited the  PFC  response  to  SE and  these data  have not  usually been  shown.  The 
experiments presented  have  been  performed  several, times  and  the  results  are  very 
reproducible. Thus, data shown are from representative experiments. 
Results 
Derivation  and Characterization  of T Cell Hybridomas and Suppressor Factors.  The 
characteristics of the T  cell hybridoma-derived suppressor factors used in these 
experiments are summarized in Table I, Most of these results have been reported 
elsewhere (14-16,  22,  23).  T  cell hybridomas producing  GT-TsF1  (367A5.4) 
and GAT-TsF1  (258C4.4) were derived by fusing GT- or GAT-primed splenic 
T  cells with BW5147 (14). The GT-TsF2-producing hybridoma (469B5.A5) was 
derived by fusion  of T  cells  from  B10.A  mice  that  had  been  injected with  a 
mixture of monoclonal GT-TsF 1 plus 10 ng GT (16). For studies reported here, KAPP,  SORENSEN, AND  PIERCE 
TABLE  I 
Characteristics of T Cell Hybridomas and Suppressor Factors* 
1965 
Suppressor T cell  Antigenic 
Hybridoma  donor  Type TsF  MHC re-  specificity*  Idi°type° 
striction 
Strain  H-2  GAT  GT  GA  CGAT  GA-I 
367A5.4  CBA  k  GT-TsFI  none  +  +  -  NT  !  NT 
469B5.A5  B10.A  a  GT-TsF2  I-J  k  +  +  -  +  - 
258c4.4  DBA/1  q  GAT-TsF1  none  +  -  +  +  + 
762B3.7  B10.Q  q  GAT-TsF2  H-2  q  +  -  +  NT  NT 
372B3.5  B10  b  GAT-TsF1  none  +  +  -  +  NT 
372D6.5  B10  b  GAT-TsF2  I-J  b  +  +  -  +  NT 
* All hybridomas were produced by fusion of antigen-primed splenic T cells with the AKR thymoma 
BW5147.Ag.1.4. 
* Binding specificity was determined by filtration through antigen-Sepharose beads as described in 
Materials and Methods. Suppressive activity was completely removed (+) or not removed at all (-) 
(14, 15, 22). 
0 Expression of determinants  that cross-react with mouse anti-GAT antibodies. The CGAT idiotype 
is expressed by GT-binding antibodies; the GA-1 idiotype is expressed by GA-binding antibodies 
(22). The antibodies were coupled to Sepharose and the suppressor factors were filtered through; 
suppressive activity was completely removed (+) or not removed at all (-) (15, 22). 
! Not tested. 
we constructed an H-2q-restricted GAT-TsF2 (762B3.7)  by fusing T  cells from 
B10.Q  mice  previously  injected  with  GAT-TsF1  (258C4.4)  plus  10  ng  GAT. 
GAT-specific suppressor T  cells from C57BL/10  mice, which are responders to 
GAT,  were  induced  by  injection  of neonatal  mice  with  GAT-pulsed  macro- 
phages.  Restimulation  of spleen  cells  from these  mice as adults  by incubation 
with GAT  in  vitro produced  activated T  cells that,  when  fused with  BW5147, 
gave rise to  two types of hybridomas (15).  One  of these  is antigen-specific but 
genetically unrestricted  (372B3.5),  a  GAT-TsF1  by analogy with  367A5.4  and 
258C4.4.  The  other  type  of suppressor  T  cell  hybridoma  is  represented  by 
372D6.5,  which  is  antigen  specific  and  genetically  restricted  and  therefore 
referred to as GAT-TsF2. 
As mentioned  above, all of the  suppressor factors derived  from these  hybri- 
domas  are  antigen  specific  in  suppressive  activity  and  all  have  binding  sites 
specific for the inducing antigen.  Analysis of the fine specificity of these factors 
has  been  determined  by  the  ability  of these  factors  to  bind  Sepharose  beads 
coupled  with  the  related  polymers, GAT,  GT,  or L-glutamic acid6°-L-alanine  4° 
(GA).  All  of these  factors  bind  to  GAT  whether  they  are  induced  by GT  or 
GAT.  The factors induced  by GT  bound  GT but not GA, whereas the factors 
induced by GAT  segregated  into two classes: those which bound  GAT and GA 
(258C4.4  and  762B3.7)  and  those  which  bound  GAT  and  GT  (372B3.5  and 
372D6.5). The expression of determinants on these suppressor factors that cross- 
react with idiotypic determinants on antibodies to GAT and GA has been assessed 
only in a limited fashion. Nevertheless, the emerging pattern indicates that all of 
the  GAT- and  GT-binding  factors that  have been  tested are  bound  by guinea 
pig anti-CGAT antibodies (15, 22, 23) and that the one GT(GAT) binding factor 
(469B5.A5)  tested  for binding  to anti-GA-1  does not.  On  the  other  hand,  the 
GA-binding  factor,  258C4.4,  was  bound  by  both  anti-CGAT  and  anti-GA-1. 1966  SUPPRESSOR T  CELL  INTERACTIONS 
Since  the  anti-CGAT  is  now  known  to  contain  small  amounts  of anti-GA-1 
activity (24), the reactivity of 258C4.4 with anti-CGAT is probably the result of 
interaction  with  the  contaminating  antibodies.  The  correlation  between  GT- 
binding activity and the expression of the CGAT idiotype and the GA-binding 
activity with the expression of the GA-1 idiotype was originally defined for GAT- 
specific antibodies (25). Interestingly, this pattern is also reflected in the limited 
number of monoclonal suppressor factors that have been examined. 
Affinity Purification of TsF1  and  TsF2 Under Reducing and Nonreducing  Condi- 
tions.  GT-TsF1  (367A5.4)  and  GT-TsF2  (469B5.A5)  were  filtered  through 
GT-Sepharose beads in  the presence or absence of 5  mM  DTT. The effluents 
were collected, the beads washed extensively, and the bound material was then 
eluted  with  2  M  KCI.  All  fractions  were  dialyzed  and  assayed  for  biological 
activity  in  cultures  of  B10.BR  spleen  cells  stimulated  with  GT-MBSA  or  SE 
(Table II).  It is clear that  GT-TsF1  binds to GT-Sepharose and that  2  M  KC1 
elutes  the  biologically active  material  in  the  presence or absence  of reducing 
agent.  By contrast, GT-TsF2 binds to and can be eluted from GT-Sepharose in 
the absence of reducing agent,  but in the presence of 5  mM DTT, neither the 
effluent nor the eluate alone are active. Adding both the effluent and eluate to 
culture reconstitutes the suppressive activity of TsF2. This suggests that, in the 
native state,  GT-TsF2  is  a  complex of at least  two polypeptide chains,  one of 
which  is  antigen  binding,  held  together  by disulfide  bonds.  The  same  results 
have been obtaind with TsF1 and TsF2 derived from H-2  q and H-2  b hybridomas 
(not shown). 
The next experiment demonstrated that the determinant encoded by the I-J 
subregion of the H-2 complex is on the same polypeptide chain as the antigen- 
binding site in TsF1  (Fig.  1),  but is on the non-antigen-binding polypeptide in 
TsF2  (Fig.  2).  The adsorption  of TsF1  and  TsF2  with  GAT-Sepharose in  the 
presence of 5 mM DTT was performed as described in the previous experiment. 
TABLE  II 
Affinity Put,cation of GT-TsF1 and GT-TsF2 Using Reducing or 
Nonreducmg Conditions 
TsF  GT-Sepharose 
fraction 
$5o U/ml* 
Minus DTT  Plus DTT 
GT-TsF1 (367A5.4)  Unfractionated  13,000  21,000 
Effluent A  <1,000  4,400 
Eluate B  75,000  75,000 
A + B  46,000  75,000 
GT-TsF2 (469B5.A5)  Unfractionated  100,000  80,000 
Effluent A  <5,000  <5,000 
Eluate B  130,000  < 10,000 
A + B  90,000  104,000 
* Hybridoma supernatant fluids containing GT-TsF1 or GT-TsF2 were filtered 
through GT-Sepharose in the presence or absence of 5 mM DTT. Unfraction- 
ated factors, effluents, and material eluted with 2 M KC1 were dialyzed, and 
various dilutions were added to spleen cells from B10.BR mice stimulated with 
GT-MBSA or SE. No suppression of SE PFC was observed (data not shown). KAPP,  SORENSEN,  AND  PIERCE 
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FIGURE 1.  GAT-TsF1  (372B3.5) was fractionated  over GAT-Sepharose in the presence of 
DTT, and the effluent and KC1 eluate were subsequently filtered through anti-I-J°Sepharose 
beads in the absence of DTT. Effluents and KCI eluates were collected, dialyzed, and added 
to cultures of spleen cells from C57BL/10  mice. Cultures were stimulated with GAT or SE 
(not shown) and the results expressed as the percent  of the control PFC response which was 
365 PFC/cuhure in this experiment. 
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FIGURE 2.  GAT-TsF2 (372D6.5) was fractionated and assayed as described in legend to Fig. 
I. The control PFC response to GAT in this experiment was 395 PFC/cuhure. 
After dialysis against  PBS,  the effluents and  eluates were separately applied to 
anti-I-J  b Sepharose  beads;  the  effluents were  collected,  the  beads  washed  with 
PBS, and the adsorbed factors eluted with 2  M  KCI. These fractions were again 
dialyzed against PBS and added at a  1:10,000  final dilution to C57BL/10 spleen 
cell cultures stimulated with GAT  or SE. The results, as percent of the control 
response  to  GAT,  are  shown  in  parentheses.  GAT-TsF1  (372B3.5)  activity is 
eluted from GAT-Sepharose and  this activity can subsequently  be adsorbed to 
and eluted  from anti-I-J  b Sepharose (Fig.  1).  Our  interpretation  of this experi- 
ment is that GAT-TsF1  is composed of a  single polypeptide chain bearing both 
the antigen-binding site and I-J determinant.  GAT-TsF2 (372D6.5), as shown in 
Table II, is dissociated into two chains by the reduction  of disulfide bonds with 
DTT; one of these chains is antigen binding while the other is not.  Subsequent 
filtration  of the  isolated  chains  through  anti-I-J  b Sepharose  demonstrated  that 1968  SUPPRESSOR T  CELL  INTERACTIONS 
the  non-ABC  is  adsorbed  to and  eluted  from anti-I-J  Sepharose,  whereas  the 
ABC  is  not  adsorbed  by anti-I-J  b Sepharose  (Fig.  2).  Thus,  we  conclude that 
GAT-TsF2 is composed of two polypeptide chains; one is antigen-binding and I- 
J-  and  the  other  is  non-antigen-binding  but  I-J  +.  Identical  results  have  been 
observed with GAT-TsF2 from H-2  q and GT-TsF2 from H-2  a T  cell hybridomas 
(data not shown). 
Since a  mixture of the isolated chains of GAT- (or GT-) TsF2  reconstituted 
the biological activity of this factor,  we  wondered whether the  isolated chains 
actually reassociated in a covalently linked form by reformation of the disulfide 
bridge, a phenomena that has been reported for Ig heavy and light chains (26). 
To  examine  this  possibility,  isolated  ABC-,I-J +  and  ABC +,  I-J-  chains  from 
469B5.A5 GT-TsF2 were mixed together and refiitered through GT-Sepharose 
in  the  absence  of reducing  agents.  If the  chains  had  reassociated  in  a  stable 
covalent  linkage,  the  biological activity would  have  been  detected  in  the  KCI 
eluate, whereas if the chains did not reassociate,  then neither the effluent nor 
the eluate would be active and biological activity would require mixture of the 
effluent and eluate.  The results,  shown  in Table III, display the latter pattern 
and  thus  indicate  that  biological  activity can  be retained by isolated chains of 
TsF2 in the absence of covalent linkage between the chains. 
Although  the  data  in  Table  III  suggest  that  reformation  of the  interchain 
disulfide  bonds  is  not  essential  to  the  biological  activity of TsF2,  the  relative 
importance of disulfide bonds and/or sulfhydryl groups of TsF2 is illustrated in 
Table IV.  In this experiment, TsF1  and TsF2 were reduced with 5  mM DTT 
and adsorbed to anti-I-Jb-Sepharose beads.  The effluents and  KC1 eluates were 
collected and  a  portion  of each  was  incubated  with  10  mM  iodoacetamide to 
alkylate  the  sulfhydryl groups.  After  dialysis,  the  suppressive  activities  of the 
effluents and  eluates  were assayed.  Reduction  and  alkylation  had  little or  no 
effect on the biological activity of GAT-TsF1, but abolished the ability of the I- 
J+ and I-J- chains of GAT-TsF2 to suppress the response to GAT (Table IV). 
TABLE  III 
Do Isolated Chains from GT-TsF2 Reassociate? 
469B5.A5  $50 U/ml 
Isolated chains*  GT-Sepharose 
absorption*  Exp. 1  Exp. 2 
ABC-I-J  +  ABC+I-J  - 
GT-MBSA  SE  GT-MBSA  SE 
+  -  None  <4,000  <4,000  NT  0  NT 
-  +  None  <4,000  <4,000  NT  NT 
+  +  None  110,000  <4,000  32,000  <3,000 
+  +  Effluent (A)  <4,000  <4,000  <3,000  <3,000 
+  +  Eluate (B)  <4,000  <4,000  <3,000  <3,000 
+  +  (A) + (B)  80,000  <4,000  99,000  <3,000 
* TsF2 from 469B5.A5 were separated into two chains by filtration through GT-Sepharose in the 
presence of 5.0 mM DTT. 
* Isolated chains from 469B5.A5 were dialyzed to remove DTT, mixed together,  and filtered 
through GT-Sepharose in the absence of DTT. The effluent, eluate, and mixtures of the two were 
assayed for suppressive activity. 
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TABLE  IV 
Effect of Reduction and Alkylation on TsF I and TsF2 Activity 
1969 
Anti-I-J  b Sepharose  Percent control PFC re- 
TsF  fractionation +  sponse* 
DTT*  Untreated  Alkylated 
GAT-TsF 1 (372B3.5) 
GAT-TsF2 (372D6.5) 
Unfractionated  < I 0  NT  ! 
Effluent A  74  103 
Eluate B  <10  38 
A +  B  NT  NT 
Un~actionated  15  NT 
Effluent A  108  147 
Eluate B  97  205 
A +  B  <10  110 
* Unfractionated factors and the isolated chains were added to cultures of spleen 
cells from B10 mice at a  final dilution of 1:10,000. Cultures were stimulated 
with GAT or SE; none of the fractions inhibited responses to SE.  The data 
shown represent the percent of the control response to GAT in the absence of 
TsF, which was 405 PFC/culture. 
* TsF1 and TsF2 were equilibrated with 5 mM DTT and filtered through anti- 
I-J  b Sepharose; adsorbed  material  was eluted  with KCI.  The  isolated chains 
were  dialyzed  to  remove  DTT  and  KCI  and either not treated  further or 
alkylated by incubation with  10 mM iodoacetamide at room temperature for 
20 min followed by dialysis and testing. 
0 Not tested. 
TABLE  V 
Kinetics ofSuppression  ~TsF2 
Group 
Day added to culture*  PFC/Culture 
ABC  + I-J-  ABC- I-J  +  GAT  SE 
A  -  -  435  9,990 
B  0  -  365  6,015 
C  -  0  420  8,400 
D  0  0  70  6,285 
E  1  1  580  7,035 
F  2  2  530  6,210 
G  1  0  560  4,380 
H  2  0  600  6,975 
I  0  1  40  8,205 
J  0  2  <5  8,295 
K  0  3  20  11,600 
L  0  4  524  10,340 
* Isolated chains from 372D6.5 GAT-TsF2 were added to spleen cells from BI0 
mice at 1:10,000 final dilution at culture initiation (day 0) or on day 1, 2, 3 or 
4. Cultures were stimulated with GAT or SE, and IgG PFC responses against 
GAT and SE were assayed on day 5. 
Kinetics of the Addition  of Isolated  TsF2 Chains to Culture.  After  observing  that 
the isolated chains from  TsF2  could  suppress  immune  responses  without  disulfide 
linkage  between  the  chains,  we  asked  whether  both  chains  needed  to  be  added 
to the  culture  simultaneously.  The  results  of one  such  experiment  are  shown  in 
Table  V.  Neither  I-J  +  nor  I-J-  chains  suppressed  singly,  and,  when  mixed 1970  SUPPRESSOR T  CELL  INTERACTIONS 
together, suppressed GAT-specific responses only when added at culture initia- 
tion and not if added 24 or 48 h later. Similarly, unfractionated TsF2 suppressed 
responses only when added at culture initiation (not shown). Addition of the I- 
J÷  chain  at  time  0  and  the  ABC  at  1  or  2  d  did  not  reconstitute suppressive 
reactivity. However, if the ABC is added to cultures at initiation, then suppression 
can be reconstituted by the addition of the I-J  + chain on day 1, 2, or 3. 
Are Heterologous Mixtures of the Isolated Chains  from TsF2 Factors from Different H- 
2 Haplot~,pes hnmunosuppressive?  The last issues to be addressed  in  this report 
are (a) a  comparison of the restriction patterns  in suppressive activity between 
TsF1 and TsF2, and b) whether ABC from one TsF2 can be recombined with I- 
J÷ chains from another TsF2 with reconstitution of suppressive activity, and, if 
so, whether the restriction pattern is dictated by the haplotype of the I-J  ÷ chain. 
The PFC responses to GAT or GAT-MBSA are inhibited by GAT-TsF1 derived 
from mice that are syngeneic or aliogeneic to the responding spleen cells (Table 
VI).  There is  no significant difference in  the  degree or extent of suppression 
observed in responses by strains of mice that are responders or nonresponders 
to  GAT.  Moreover,  GAT-TsF1  from  responder  mice  (372B3.5)  suppressed 
responses to GAT-MBSA by nonresponder B10.Q and  B10.S spleen cells and 
responses to GAT and GAT-MBSA by responder BALB/c and B10 spleen cells. 
Similarly, GAT-TsF1  from nonresponder mice (258C4.4) suppressed responses 
by spleen cells from both responder and nonresponder mice. 
By  contrast,  intact  two-chain  factors  have  been  shown  to  be  restricted  in 
suppressive activity by the I-J subregion of the H-2 gene complex (15,  16). The 
same  restriction  is  observed when  isolated TsF2  chains are  mixed together in 
homologous pairs and added to cultures of syngeneic or allogeneic spleen cells 
(Table VII). Because all of the strains to be tested are able to respond to GAT- 
MBSA and all of the factors can bind to GAT, the cultures in these experiments 
were all  challenged with  GAT-MBSA rather than  some with GAT-MBSA and 
TABLE  VI 
Suppression by TsF1 Is Not MHC-Restricted 
GAT-TsF 1  Day 5 IgG PFC/culture*  Responding  H-2 
spleen cells  added*  GAT  GAT-MBSA  SE 
Bl0  b  --  645  350  1180 
372B3.5  <10  <10  1345 
258C4.4  <10  <10  2000 
B10.Q  q  --  <10  363  1310 
372B3.5  <10  <I0  1500 
258C4.4  <10  <10  1320 
BALB/c  d  --  265  145  850 
372B3.5  <10  40  815 
258C4.4  <10  25  850 
B10.S  s  --  20  320  1450 
372B3.5  <10  50  1280 
258C4.4  15  15  1020 
* GAT-TsFI (372B3.5 [H-2  b] and 258C4.4 [H-2q]) were added to spleen cell cultures 
at initiation, at a final dilution of 1:10,000. 
* Cultures were stimulated with GAT, GAT-MBSA,  or SE, and PFC responses to GAT 
and SE were assayed on day 5. KAPP,  SORENSEN,  AND  PIERCE 
TABLE  VII 
A re Heterologous Mixtures of TsF2 Chains Immunosuppressive? 
1971 
Experiment 
Haplotype*  S~0 U/mlinresponseto GAT- 
MBSA* 
I-J  +  ABC  ÷  B10  BI0.BR 
a  a  <10,000  54,000 
b  b  73,000  <10,000 
a  b  <10,000  <10,000 
b  a  <10,000  <10,000 
BIO.Q  B10.BR 
a  a  <10,000  60,000 
q  q  120,000  <10,000 
a  q  <10,000  <10,000 
q  a  15,000  <10,000 
* Isolated chains from 469BS.A5 (H-2a),  372D6.5  (H-2b),  and 762B3.7  (H-2  q) 
were prepared as described in Table II. 
* Isolated chains were mixed, diluted, and added to cultures of spleen cells from 
the indicated strains, which were stimulated with GAT-MBSA. PFC responses 
to GAT were assayed on day 5. 
others with GT-MBSA. The first combination to be tested was isolated chains 
from 372D6.5 (H-2 b) and 469B5.A5 (H-2  a) (experiment 1, Table VII). It is clear 
that the suppression of responses by B 10 spleen cells occurred only when the I- 
J+ and ABC  + chains from 372D6.5 were mixed together and that suppression of 
responses by B10.BR spleen cells occurred only when both the I-J  + and ABC  + 
chains derived from 469B5.A5  were mixed. The same phenomenon occurred 
when chains from 469B5.A5 (H-2  a) and 762B3.7 (H-2  q) were mixed (experiment 
2, Table VII). A small degree of suppression, ,~ 10%  of the suppressive activity 
of 762B3.7,  has occasionally been observed in the responses by B10.Q spleen 
cells incubated with I-J  + chain of H-2  q and the ABC  + chain from H-2L 
There are two straightforward interpretations of these data. First, there could 
be steric hindrance or restrictions in  the ability of two chains from different 
haplotypes to deliver a functional suppressive signal. Alternatively, chains from 
two different haplotypes could form a functional unit, but the target cells used 
might not  bear appropriate  receptors that  recognize both  chains.  To  choose 
between these alternatives, we tested the ability of these recombinant molecules 
to inhibit responses by spleen cells from F1 hybrid mice (Table VIII). These data 
confirm a  previous observation that TsF2  molecules can suppress responses of 
F1 mice if one of the parental mice in the F1  is syngeneic with the TsF2 donor 
(16). However, none of the putative recombinant TsF2 suppressed responses by 
spleen cells from F1 mice. 
Discussion 
We  previously presented evidence that  two  functionally different types of 
GAT/GT-specific suppressor factors could be produced by T  cell hybridomas 
(14-16).  Both types of factors were antigen specific in suppressive activity and 
both  had  antigen-specific binding  sites.  Nevertheless,  these  factors  could  be 1972  SUPPRESSOR T  CELL INTERACTIONS 
TABLE  VIII 
Are Heterologous Mixtures of TsF2 Chains Immunosuppressive When Tested on Fl Spleen 
Cells? 
Experiment 
Haplotype*  $50 U/ml in Response to GAT-MBSA* 
I-J  +  ABC*  BI0  BI0.Q  (BI0 x BI0.Q)F: 
q  q  <10,000  35,000  56,000 
b  b  43,000  <10,000  51,000 
q  b  <10,000  <10,000  <10,000 
b  q  <10,000  <10,000  <10,000 
B10  B10.BR  (B10 ×  CBA)F, 
a  a  <10,000  80,000  34,000 
b  b  36,000  <10,000  47,000 
a  b  <10,000  <10,000  <10,000 
b  a  <10,000  <10,000  <10,000 
* Isolated chains from 762B3.7 (H-2q),  372D6.5 (H-2b),  and 469B5.A5 (H-2") were prepared 
as described in Table II. 
* Isolated chains were mixed, diluted, and added to cultures of spleen cells from the indicated 
strains, which were stimulated with GAT-MBSA.  PFC responses to GAT were assayed on 
day 5. 
distinguished by the pattern of suppressive activity on responses by allogeneic 
mice.  The  factors we  call  first-order factors  (TsF1)  suppress  in  a  genetically 
unrestricted manner; in previous studies, TsF1  obtained as extracts from mice 
that  are nonresponders to  GAT  suppressed  responses by all  other allogeneic 
nonresponder mice (9).  Furthermore, responses of mice that were responders to 
GAT could be suppressed by extract TsF 1 from nonresponders only if the spleen 
cells were pretreated with TsF1  before antigenic stimulation (9,  12).  The data 
in Table VI clearly show that hybridoma-derived TsF1  suppressed across allo- 
geneic barriers  when added  to  cultures at  initiation,  whether the  spleen  cell 
cultures were derived from responder or nonresponder mice. The reason for 
the  discrepancy in  the  ability  of nonresponder-derived TsF1  to  suppress  re- 
sponder strains is unknown, but may be related to differences in extracted and 
hybridoma-derived TsF1 or to the fact that the mice used are healthier now that 
Sendai virus has been eliminated from our mouse colony. 
By contrast to TsF 1, the second-order factors (TsF2) are genetically restricted 
and suppression is only manifest when the strain of origin of TsF2 and the target- 
responding spleen cells are syngeneic at the I-J subregion (15, 16). Data presented 
above clearly demonstrate that the molecular structures of these two types of 
factors are also  different.  As  previously suggested  (27),  TsF1  molecules are 
composed of a single polypeptide chain that bears both the antigen-binding site 
and  I-J  determinant, as demonstrated by the failure of reduction of disulfide 
bonds to separate these markers during subsequent immunoadsorption proce- 
dures (Table IV). Furthermore, reduction and alkylation failed to significantly 
reduce the biological activity of TsF1 (Table IV), which suggests that if disulfide 
bonds or sulfhydryl groups are present in TsF1,  they are not essential to the 
biological activity. By contrast, undenatured TsF2 bears both the antigen-binding 
site and I-J determinant, but these determinants can be separated by reduction KAPP, SORENSEN, AND PIERCE  1973 
of disulfide  bonds  (Table  II).  It  is  interesting that  both  the  antigen-binding 
activity and binding by anti-I-J antibodies are detectable with the intact, cova- 
lently associated  chains  as  well  as  the  isolated  chains.  Thus,  it  appears  that 
conformational effects of the association of the two chains do not contribute 
significantly to the antigen-binding activity or to the I-J structure. Although the 
isolated chains of TsF2 do not reassociate by reformation of the disulfide bonds 
(Table  III),  the disulfide bonds and/or sulfhydryl groups  are relevant to  the 
biological activity of TsF2 since reduction and alkylation inactivates this factor 
(Table IV). Whether the inactivation is due to the fact that alkylation indirectly 
alters the activity by changing the conformation of the molecule, or to  some 
other mechanism, is not known. 
The  identification  of  two  distinct  antigen-binding  suppressor  factors  that 
regulate immune responses to the same antigen provides some new insights into 
the relationship among the numerous suppressor factors described in the litera- 
ture.  GAT/GT-TsF2  molecules resemble the carrier-specific, I-J  +,  genetically 
restricted factors described by Taniguchi and colleagues (28, 29). Because GAT/ 
GT-TsF2 factors were induced by GAT/GT-TsF1 factors, we suggest that TsF1- 
producing cells are an early cell in the pathway of suppression and that this cell 
is required for the activation of cells producing antigen-specific, major histocom- 
patibility complex (MHC)-restricted TsF2.  Whether antigen-specific, TsFl-pro- 
ducing cells are required for the generation of suppressor pathways that regulate 
responses to  other antigens is  not yet known.  However, several other factors 
have been described that inhibit responses in a genetically unrestricted manner 
(30-34) and some of these mediators are known to bear I-J determinants (31- 
33). The molecular structures of most of these mediators have not been reported 
and it may be that some of these factors are analogous to GAT/GT-TsF1.  To 
test  this  possibility  indirectly,  we  have  produced  monocional  antibodies  that 
recognize TsFI  molecules and other monoclonal antibodies that recognize all of 
the TsF2 molecules tested. We are in the process of determining whether these 
antibodies abrogate development of suppressor  T  cells to other antigens.  Al- 
though some genetically unrestricted factors may be single polypeptide chains, 
there  is  already evidence that  at  least  one  other antigen-specific,  genetically 
unrestricted  suppressor  factor  has  been  identified  that  is  composed  of two 
polypeptide chains,  one of which  is  antigen  binding and  the other  I-J  + (35). 
Clearly, resolution of the relationship between these suppressor factors awaits 
further analysis. 
Induction of MHC-restricted, I-J  + suppressor factors by stimulation with other 
suppressor factors also has been demonstrated in the hapten-specific systems of 
Dietz et al. (36) and Okuda et ai. (37).  However, in these systems it is thought 
that injection of unrestricted suppressor factors in the absence of antigen induces 
antiidiotypic suppressor T  cells whose factors ultimately stimulate third-order, 
antigen-binding,  MHC-restricted (TsF3)  molecules. On  the other hand,  Tani- 
guchi  et  al.  have  found  that  the  antigen-specific,  MHC-restricted,  two-chain 
factor interacts with an antiidiotypic T  cell that actually mediates suppression 
(38). We have not yet found an obligate need for an antiidiotypic suppressor T 
cell  in  our system,  but  such a  cell  may well  exist.  There  is,  in  our  opinion, 
insufficient information to say whether a central common pathway of  suppression 1974  SUPPRESSOR  T  CELL  INTERACTIONS 
involving  all  of the  described  suppressor  T  cells  exists  or  whether  there  are 
multiple separate pathways, each of which can cause specific inhibition. However, 
based on the fact that isotype-specific suppressor T  cells and factors (39, 40) as 
well as allotype-specific suppressor  T  cells and  factors  (41) are  also known  to 
regulate immune responses, we favor the interpretation  that there are multiple 
suppressor pathways that are complex and potentially interacting systems. 
The observation that mixtures of the isolated chains of TsF2 are immunosup- 
pressive  in  the  absence  of  covalent  association  (Table  II)  raises  interesting 
questions concerning  the mechanism  by which TsF2 molecules inhibit immune 
responses.  One issue that  we investigated was whether the two chains must be 
present simultaneously to cause suppression. The experiment shown in Table V 
demonstrates that the ABC must be added at culture initiation, but that the I-J  + 
chain  can be added at any time up to day 3 of a  5-d culture period.  Although 
this was an unexpected finding, it is consistent with the observation that covalent 
association between the two chains is not essential to the biological activity. As 
yet, we have no indication  of how these chains interact  with the target cell, or 
cells, or whether the chains actually reassociate to deliver the inhibitory signal, 
but the fact that the chains can be added separately provides the opportunity to 
dissect the system further. 
The  last two experiments  reported above do provide indirect  evidence sup- 
porting  the  interpretation  that  the  two  chains  must  interact  to  deliver  the 
suppressive  signal.  The  first  observation  is  that  none  of the  isolated  antigen- 
binding  and  I-J  +  chains  from  hybridomas  derived  from  three  independent 
haplotypes were able to  suppress responses of parental  strains  when  mixed  in 
nonhomologous pairs. Second, the heterologous mixtures of chains from differ- 
ent haplotypes cannot  suppress responses by spleen  cells from  FI  hybrid mice 
even  though  the  F~  mice are  suppressed by both homologous pairs  of chains. 
Since F~  mice have receptors for,  or the ability to interact  with,  TsF2 derived 
from  both  parental  mice,  there  must  be  a  further  constraint  on  the  system. 
Although  there  are  several  conceivable  explanations  for this  observation,  the 
simplest is that there is a requirement for the chains to interact at some level to 
form a  functional  suppressor signal and that  there is a  restriction  in the ability 
of isolated chains  from  different  mice  to  interact.  The  extent  to  which  these 
restrictions will apply to other MHC-restricted suppressor factors is not known. 
However, a similar restriction was reported for the I-J + chains of the unrestricted 
suppressor factors reported by Lei et al. (35). 
Summary 
We have previously reported that two types of suppressor T  cell factors (TsF) 
specific for L-glutamic acidS°-L-tyrosine  "~° (GT) or L-glutamic acid6°-L-alanine3°-L - 
tyrosine 1° (GAT) can be distinguished based upon differences in their ability to 
suppress  responses  by  allogeneic  mice.  Injection  of  GAT  or  GT  induces  a 
suppressor  T  cell  subset  that  produces  an  antigen-binding,  I-J  +,  genetically 
unrestricted,  specific suppressor factor (TsF 1). Injection of this factor plus small 
amounts of antigen  induces a  second-order suppressor T  cell that produces an 
antigen-binding,  I-J  +, genetically restricted, specific suppressor factor (TsF2). In 
this report, we demonstrate that these two factors are also biochemically distinct. KAPP, SORENSEN, AND  PIERCE  1975 
Monoclonal TsF1  molecules are  composed  of a  single  polypeptide chain  that 
bears both the antigen-binding site and I-J determinant, whereas TsF2 molecules 
are composed of two disulfide-linked polypeptide chains, one of which is antigen- 
binding and I-J-, and the other, nonantigen-binding, I-J  +. The antigen-binding 
chain must be  added at culture  initiation to achieve suppression,  but the  I-J  + 
chain can be added as late as day 3 with complete suppression observed. However, 
isolated chains from TsF2-producing hybridomas derived from three different 
haplotypes were unable to suppress immune responses when chains from heter- 
ologous TsF2 were mixed. Indirect evidence is presented that suggests that this 
restriction is because the chains fail to interact rather than the inability of the 
target cells to recognize both chains. 
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